For the Inventor, By the Inventor

Enter assignee name

Leuven, Belgium

Life Sciences Research Partners Vzw

USPTO Granted Patents = 41

CIPO Patents = 62

EPO Patents = 34

Forward Citations = 155

Loading Chart...

Loading Chart...

67 inventors (with patents filed for the assignee):

Peter Carmeliet (14 out of 21 patents)

Jean-Marie Saint-Remy (13 out of 40 patents)

Désiré Collen (7 out of 10 patents)

4. Thierry Vandendriessche (5 out of 16 patents)

5. Pieter De Bleser (5 out of 10 patents)

6. Marc G Jacquemin (5 out of 13 patents)

7. Marinee Chuah (4 out of 13 patents)

8. Diether Lambrechts (3 out of 3 patents)

9. Wim Robberecht (3 out of 3 patents)

10. Jean-Marie Stassen (3 out of 6 patents)

11. Joost Schymkowitz (2 out of 8 patents)

12. Bert Oosthuyse (2 out of 3 patents)

13. Sandro De Falco (1 out of 7 patents)

14. Frederic Rousseau (1 out of 7 patents)

15. Sonja Loges (1 out of 1 patent)

41 patents: Sort by Forward Citations

1. 12409236 - Liver-specific nucleic acid regulatory elements and methods and use thereof (2025-09-09),

2. 11814688 - Markers for determining tumor hypoxia (2023-11-14),

3. 11654201 - Liver-specific nucleic acid regulatory elements and methods and use thereof (2023-05-23),

4. 10982196 - Immunotherapy targeting intracellular pathogens (2021-04-20),

5. 10899795 - Modified epitopes for boosting CD4+ T-cell responses (2021-01-26),

6. 10662232 - Immunogenic peptides and their use in immune disorders (2020-05-26),

7. 10633707 - Markers for detecting microsatellite instability in cancer and determining synthetic lethality with inhibition of the DNA base excision repair pathway (2020-04-28),

8. 10617748 - Immunogenic control of tumours and tumour cells (2020-04-14),

9. 10294529 - Microsatellite instability markers in detection of cancer (2019-05-21),

10. 10149914 - Liver-specific nucleic acid regulatory elements and methods and use thereof (2018-12-11),

11. 10106601 - Inhibition of PLGF to treat philadelphia chromosome positive leukemia (2018-10-23),

12. 10076576 - Minimally toxic prodrugs (2018-09-18),

13. 10041126 - Monocyte biomarkers for cancer detection (2018-08-07),

14. 9862777 - Single domain antibodies against SOD1 and their use in medicine (2018-01-09),

15. 9861661 - Elimination of immune responses to viral vectors (2018-01-09),

Life Sciences Research Partners (LSRP) VZW is a non-profit organization focused on promoting research and innovation in the life sciences field. LSRP collaborates with academic, industrial, and governmental partners to support projects that drive scientific advancements and improve human health. Through its network and expertise, LSRP aims to foster cross-disciplinary research and facilitate the translation of scientific discoveries into practical applications.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

41 Patents

#9 in Leuven

#98 in Belgium

#16,183 in the World

Leuven, Belgium

Life Sciences Research Partners Vzw

Forward Citations = 155

67 inventors:

Peter Carmeliet (14 out of 21 patents)

Jean-Marie Saint-Remy (13 out of 40 patents)

Désiré Collen (7 out of 10 patents)

4. Thierry Vandendriessche (5 out of 16 patents)

5. Pieter De Bleser (5 out of 10 patents)

Please report any incorrect information to support@idiyas.com

Loading…